SYNLAB UK & Ireland:

Emma Parker

Emma Parker

Introducing Emma Parker, Business Transformation Manager at Pathology First.

Emma is currently responsible for the team implementing COVID-19 antibody testing at Pathology First. Emma explains her Pathology First journey and how she became the project leader for this crucial service.

“From as early as 11 years old I remember being interested in science and inspired by my Mum. At 32 years’ of age, she was diagnosed with breast cancer and my original plan was to find a cure.”

“I studied for a BSc in Immunology at the University of East London prior to becoming a Biomedical Scientist, completing my specialist portfolio in Medical Microbiology. I then secured a team manager role by gaining a MSc in Biomedical Science.

I was working for the pathology department of Southend Hospital when it became part of iPP, which is now part of SYNLAB. I was majorly involved in implementing the total laboratory automation (BD Kietsra) in the new hub lab. I received Lean training before starting my Level 5 diploma in Leadership and Management.

I was lucky to join the new SYNLAB Transformation System (STS) team and I completed my Lean green belt training, my STS certification, my diploma and secured my Business Transformation Manager role.

As the pandemic started to hit, I wanted to support the team in any way I could so applied for the lead role in managing the setup of COVID-19 antibody testing for Pathology First. This urgent project brought together my STS background and lab leadership experience, creating a workstream involving all the pathology disciplines. It not only brings new testing capabilities, it involves a lot of key people from both hospital trusts and the three laboratories that make up Pathology First.”

Pathology First is one of our NHS partnerships. Created in 2014, it has delivered a major transformation of pathology services for two NHS hospital trusts, which are now part of the recently formed Mid and South Essex NHS Foundation Trust. Patients and clinicians benefit from faster testing turnaround times, waiting times for phlebotomy blood tests have reduced significantly, and the NHS has saved up to 20p in every pound spent on pathology testing services. Up until the start of the pandemic, Pathology First was processing an average of 56,000 tests every day.

Latest SYNLAB UK & Ireland News
SYNLAB LABORATORY SERVICES 2020 ROUND UP

2020 was a challenging year for everyone. We’d like to thank all of our customers for their continued loyalty last year, we look forward to…

Read More (about 'SYNLAB LABORATORY SERVICES 2020 ROUND UP')
SYNLAB LABORATORY SERVICES 2020 ROUND UP

2020 was a challenging year for everyone. We’d like to thank all of our customers for their continued loyalty last year, we look forward to…

Read More (about 'SYNLAB LABORATORY SERVICES 2020 ROUND UP')
SYNLAB partners with Bristol Airport to provide first class Covid-19 testing service

15th December 2020 SYNLAB is teaming up with Bristol Airport to provide its customers with access to a high quality Covid-19 testing service which could…

Read More (about 'SYNLAB partners with Bristol Airport to provide first class Covid-19 testing service')
Press Statement: SYNLAB UK & Ireland Announced As Partner In Major Pathology Partnership Contract

6th October 2020 We are delighted to announce that SYNLAB UK & Ireland will become the new pathology partner to Guy’s and St Thomas’ NHS…

Read More (about 'Press Statement: SYNLAB UK & Ireland Announced As Partner In Major Pathology Partnership Contract')
Supporting UEFA to Restore European Football Competitions and Matches in a Safe Environment.

Delivering COVID-19 Testing Across All UEFA Competitions We are proud to be supporting UEFA, governing body of European football, with COVID-19 testing across all UEFA…

Read More (about 'Supporting UEFA to Restore European Football Competitions and Matches in a Safe Environment.')
SYNLAB Announce Agreement with Arquer Diagnostics for Bladder Cancer Testing

13 July 2020 SYNLAB UK & Ireland and Arquer Diagnostics, a UK-based company committed to manufacturing and marketing innovative, non-invasive tests for diagnosing and monitoring…

Read More (about 'SYNLAB Announce Agreement with Arquer Diagnostics for Bladder Cancer Testing')
SYNLAB Laboratory Services Maintains ISO 15189:2012 UKAS Accreditation

7th April 2020 – SYNLAB Laboratory Services, part of Europe’s leading medical diagnostics provider SYNLAB Group, is pleased to announce that the company has successfully…

Read More (about 'SYNLAB Laboratory Services Maintains ISO 15189:2012 UKAS Accreditation')
SYNLAB Laboratory Services Maintains UKAS Accreditation

3rd April 2020 – SYNLAB Laboratory Services, a specialist workplace drug and alcohol testing laboratory, today announced that the company has successfully maintained its United…

Read More (about 'SYNLAB Laboratory Services Maintains UKAS Accreditation')
Press Statement: SYNLAB UK & Ireland Confirmed as Preferred NHS Strategic Partner

21 January 2020 SYNLAB UK & Ireland has been confirmed as the preferred strategic partner to transform and deliver NHS pathology services in South East London. SYNLAB…

Read More (about 'Press Statement: SYNLAB UK & Ireland Confirmed as Preferred NHS Strategic Partner')